share_log

Tempest Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Vantage II, L.P.(11.0%),Versant Vantage II GP, L.P.(11.0%), etc.

SEC announcement ·  Feb 8 17:46
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more